StockWatch
·
Medical/Dental Instruments
Quarterly ResultMay 15, 2026, 04:48 PM

Retractable Technologies Q1 Net Sales $7.2M; Operating Loss $6.2M

AI Summary

Retractable Technologies, Inc. reported total net sales of $7.2 million for Q1 2026, a decrease from $8.3 million in the prior year. The company's operating loss widened to $6.2 million from $4.7 million, resulting in a net loss of $4.2 million. In response to financial performance, the company reduced its workforce by approximately 16% in April 2026, expecting $2.2 million in annual savings. While international sales increased, domestic sales declined, and operating expenses rose due to non-recurring costs.

Key Highlights

  • Q1 2026 net sales were $7.2 million, down from $8.3 million in Q1 2025.
  • Q1 2026 operating loss increased to $6.2 million from $4.7 million in Q1 2025.
  • Net loss for Q1 2026 was $4.2 million.
  • Workforce reduced by approximately 16% in April 2026, saving an estimated $2.2 million annually.
  • International revenues increased 42.4% in Q1 2026, driven by EasyPoint ® needle sales.
  • Domestic revenues decreased 20.0% in Q1 2026, with unit sales down 11.5%.
  • Operating expenses increased 14%, including $900 thousand in non-recurring consulting and donations.
  • Tariff expenses significantly decreased to $11.6 thousand in Q1 2026 due to mitigation efforts.